Show simple item record

dc.contributor.authorTo, Minh D.
dc.contributor.authorQuigley, David A.
dc.contributor.authorMao, Jian-Hua
dc.contributor.authorDel Rosario, Reyno
dc.contributor.authorHsu, Jeff
dc.contributor.authorHodgson, Graeme
dc.contributor.authorBalmain, Allan
dc.contributor.authorJacks, Tyler E
dc.date.accessioned2014-02-03T16:42:08Z
dc.date.available2014-02-03T16:42:08Z
dc.date.issued2011-08
dc.date.submitted2011-07
dc.identifier.issn1541-7786
dc.identifier.issn1557-3125
dc.identifier.urihttp://hdl.handle.net/1721.1/84644
dc.description.abstractAlterations in DNA copy number contribute to the development and progression of cancers and are common in epithelial tumors. We have used array Comparative Genomic Hybridization (aCGH) to visualize DNA copy number alterations across the genomes of lung tumors in the Kras[superscript LA2] model of lung cancer. Copy number gain involving the Kras locus, as focal amplification or whole chromosome gain, is the most common alteration in these tumors and with a prevalence that increased significantly with increasing tumor size. Furthermore, Kras amplification was the only major genomic event among the smallest lung tumors, suggesting that this alteration occurs early during the development of mutant Kras-driven lung cancers. Recurring gains and deletions of other chromosomes occur progressively more frequently among larger tumors. These results are in contrast to a previous aCGH analysis of lung tumors from Kras[superscript LA2] mice on a mixed genetic background, in which relatively few DNA copy number alterations were observed regardless of tumor size. Our model features the Kras[superscript LA2] allele on the inbred FVB/N mouse strain, and in this genetic background, there is a highly statistically significant increase in level of genomic instability with increasing tumor size. These data suggest that recurring DNA copy alterations are important for tumor progression in the Kras[superscript LA2] model of lung cancer and that the requirement for these alterations may be dependent on the genetic background of the mouse strain.en_US
dc.language.isoen_US
dc.publisherAmerican Association for Cancer Researchen_US
dc.relation.isversionofhttp://dx.doi.org/10.1158/1541-7786.mcr-11-0219en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alike 3.0en_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.sourcePMCen_US
dc.titleProgressive Genomic Instability in the FVB/Kras[superscript LA2] Mouse Model of Lung Canceren_US
dc.typeArticleen_US
dc.identifier.citationTo, M. D., D. A. Quigley, J.-H. Mao, R. Del Rosario, J. Hsu, G. Hodgson, T. Jacks, and A. Balmain. “Progressive Genomic Instability in the FVB/KrasLA2 Mouse Model of Lung Cancer.” Molecular Cancer Research 9, no. 10 (October 16, 2011): 1339-1345.en_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorJacks, Tyler E.en_US
dc.relation.journalMolecular Cancer Researchen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsTo, M. D.; Quigley, D. A.; Mao, J.-H.; Del Rosario, R.; Hsu, J.; Hodgson, G.; Jacks, T.; Balmain, A.en_US
dc.identifier.orcidhttps://orcid.org/0000-0001-5785-8911
mit.licenseOPEN_ACCESS_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record